{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:50:06Z","timestamp":1792806606454,"version":"4.5.0"},"reference-count":55,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>p16-expression are implemented in the TNM8 classification of oropharyngeal cancer (OPSCC). Based on a nationwide cohort, we provide a detailed description of subsite variation in the age-standardised incidence-rates of OPSCC alongside an evaluation of the prognostic impact of p16-expression according to subsite after primary radiotherapy (RT).\nPatient\/material and methods: A total of 8,462 Danish OPSCC patients from 1986 to 2020 were identified in the DAHANCA-database, and tumours were grouped into \u2018tonsil\/base of tongue (BOT)\u2019, \u2018neighbouring subsites\u2019 and \u2018distant subsites\u2019. Subsite-specific age-standardised incidence-rates were calculated, and outcome-analysis (loco-regional control, disease-free survival and overall-survival 5 years after the completion of RT) stratified by p16-status\/subsite and restricted to curatively treated patients only (N\u00a0=\u00a03,387) was performed.\nResults: A 5-fold increase in the age-standardised incidence of OPSCC was observed and could be ascribed to the rise in p16-positive tumours of tonsil\/BOT and neighbouring subsites only as neither the incidence rates nor the proportion of p16-positivity in distant subsites tumours changed over time. The prognostic impact of p16-status for all endpoints differed significantly across tumour subsites with the strongest association found in tonsil\/BOT tumours, a diminishing but still significant impact in neighbouring subsite tumours and no significant impact in tumours arising in distant subsites.\nInterpretation: Our findings suggest that grouping all p16-positive OPSCC as one entity for staging and prognostication, as currently done in TNM8, is too simple as it does not accurately depict the differences in tumour biology and the consequent treatment response.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.44027","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:53:37Z","timestamp":1755240817000},"page":"1071-1078","source":"Crossref","is-referenced-by-count":6,"title":["Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986\u20132020"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-7692","authenticated-orcid":false,"given":"Pernille","family":"Lassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-3193","authenticated-orcid":false,"given":"Jan","family":"Alsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-0026","authenticated-orcid":false,"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4284-9040","authenticated-orcid":false,"given":"Christina Caroline","family":"Plaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-2082","authenticated-orcid":false,"given":"Christian","family":"Maare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3929","authenticated-orcid":false,"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8179","authenticated-orcid":false,"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"121043","doi-asserted-by":"crossref","unstructured":"Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med. 1982;306:1151\u20135.","DOI":"10.1056\/NEJM198205133061905"},{"key":"121044","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJM198205133061905","DOI":"10.1056\/NEJM198205133061905"},{"key":"121045","doi-asserted-by":"crossref","unstructured":"Gillison ML. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709\u201320.","DOI":"10.1093\/jnci\/92.9.709"},{"key":"121046","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/92.9.709","DOI":"10.1093\/jnci\/92.9.709"},{"key":"121047","doi-asserted-by":"crossref","unstructured":"D\u2019Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case\u2013control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944\u201356.","DOI":"10.1056\/NEJMoa065497"},{"key":"121048","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa065497","DOI":"10.1056\/NEJMoa065497"},{"key":"121049","doi-asserted-by":"crossref","unstructured":"Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467\u201375.","DOI":"10.1158\/1055-9965.EPI-04-0551"},{"key":"121050","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0551","DOI":"10.1158\/1055-9965.EPI-04-0551"},{"key":"121051","doi-asserted-by":"crossref","unstructured":"Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6:104\u201320.","DOI":"10.1007\/s12105-012-0368-1"},{"key":"121052","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s12105-012-0368-1","DOI":"10.1007\/s12105-012-0368-1"},{"key":"121053","doi-asserted-by":"crossref","unstructured":"Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagu\u00e9 X, Laporte L, et al. HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319\u201331.","DOI":"10.1016\/S1470-2045(14)70471-1"},{"key":"121054","doi-asserted-by":"crossref","unstructured":"Mariz Bala, Kowalski LP, William WN, de Castro G, Chaves ALF, Santos M, et al. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;156:103\u201316.","DOI":"10.1016\/j.critrevonc.2020.103116"},{"key":"121055","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103116","DOI":"10.1016\/j.critrevonc.2020.103116"},{"key":"121056","unstructured":"Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J."},{"key":"121057","doi-asserted-by":"crossref","unstructured":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992\u20138.","DOI":"10.1200\/JCO.2008.20.2853"},{"key":"121058","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2008.20.2853","DOI":"10.1200\/JCO.2008.20.2853"},{"key":"121059","unstructured":"Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J."},{"key":"121060","doi-asserted-by":"crossref","unstructured":"HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol. 2010;94(1):30\u20135.","DOI":"10.1016\/j.radonc.2009.10.008"},{"key":"121061","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2009.10.008","DOI":"10.1016\/j.radonc.2009.10.008"},{"key":"121062","doi-asserted-by":"crossref","unstructured":"Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulh\u00f8i BP, Overgaard M, et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 2011;100(1):49\u201355.","DOI":"10.1016\/j.radonc.2011.02.010"},{"key":"121063","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2011.02.010","DOI":"10.1016\/j.radonc.2011.02.010"},{"key":"121064","doi-asserted-by":"crossref","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus\u2013positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261\u20139.","DOI":"10.1093\/jnci\/djn011"},{"key":"121065","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jnci\/djn011","DOI":"10.1093\/jnci\/djn011"},{"key":"121066","doi-asserted-by":"crossref","unstructured":"Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014;113(3):310\u20136.","DOI":"10.1016\/j.radonc.2014.11.032"},{"key":"121067","unstructured":"https:\/\/doi.org\/"},{"key":"121068","doi-asserted-by":"crossref","unstructured":"10.1016\/j.radonc.2014.11.032","DOI":"10.1016\/j.radonc.2014.11.032"},{"key":"121069","doi-asserted-by":"crossref","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","DOI":"10.1056\/NEJMoa0912217"},{"key":"121070","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa0912217","DOI":"10.1056\/NEJMoa0912217"},{"key":"121071","doi-asserted-by":"crossref","unstructured":"Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl P, et al. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2022;150:1329\u201340.","DOI":"10.1002\/ijc.33876"},{"key":"121072","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ijc.33876","DOI":"10.1002\/ijc.33876"},{"key":"121073","unstructured":"O\u2019Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K,"},{"key":"121074","doi-asserted-by":"crossref","unstructured":"et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440\u201351.","DOI":"10.1016\/S1470-2045(15)00560-4"},{"key":"121075","unstructured":"https:\/\/doi.org\/"},{"key":"121076","doi-asserted-by":"crossref","unstructured":"10.1016\/S1470-2045(15)00560-4","DOI":"10.1016\/S1470-2045(15)00560-4"},{"key":"121077","doi-asserted-by":"crossref","unstructured":"Mehanna H, Taberna M, von Buchwald C, Tous S, Brooks J, Mena M, et al. HNCIG-EPIC group. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol. 2023;24:239\u201351.","DOI":"10.1016\/S1470-2045(23)00013-X"},{"key":"121078","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(23)00013-X","DOI":"10.1016\/S1470-2045(23)00013-X"},{"key":"121079","unstructured":"Marklund L, Holzhauser S, de Flon C, Zupancic M, Landin D, Kolev A,"},{"key":"121080","doi-asserted-by":"crossref","unstructured":"et al. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas. Eur J Cancer. 2020;139:192\u2013200.","DOI":"10.1016\/j.ejca.2020.08.003"},{"key":"121081","unstructured":"https:\/\/doi.org\/10.1016\/"},{"key":"121082","doi-asserted-by":"crossref","unstructured":"j.ejca.2020.08.003","DOI":"10.1088\/1475-7516\/2020\/08\/003"},{"key":"121083","doi-asserted-by":"crossref","unstructured":"Overgaard J, Jovanovic A, Godballe C, Eriksen JG. The Danish Head and Neck Cancer database. Clin Epidemiol. 2016;8:491\u20136.","DOI":"10.2147\/CLEP.S103591"},{"key":"121084","unstructured":"https:\/\/doi.org\/"},{"key":"121085","doi-asserted-by":"crossref","unstructured":"10.2147\/CLEP.S103591","DOI":"10.2147\/CLEP.S103591"},{"key":"121086","doi-asserted-by":"crossref","unstructured":"Jensen K, Friborg J, Hansen CR, Sams\u00f8e E, Johansen J, Andersen M, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149\u201351.","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"121087","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2020.07.037","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"121088","doi-asserted-by":"crossref","unstructured":"Lassen P, Overgaard J. Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression. Radiother Oncol. 2012;105:269\u201370.","DOI":"10.1016\/j.radonc.2012.09.017"},{"key":"121089","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2012.09.017","DOI":"10.1016\/j.radonc.2012.09.017"},{"key":"121090","doi-asserted-by":"crossref","unstructured":"Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, et al. Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018;36:3152\u201361.","DOI":"10.1200\/JCO.18.00684"},{"key":"121091","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.18.00684","DOI":"10.1200\/JCO.18.00684"},{"key":"121092","doi-asserted-by":"crossref","unstructured":"Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma: a prospective study. Radiother Oncol. 2012;103(1):38\u201344.","DOI":"10.1016\/j.radonc.2012.01.011"},{"key":"121093","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2012.01.011","DOI":"10.1016\/j.radonc.2012.01.011"},{"key":"121094","doi-asserted-by":"crossref","unstructured":"Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, et al. Radiation oncology in the era of precision medicine. Nat Rev Cancer. 2016;16(4):234\u201349.","DOI":"10.1038\/nrc.2016.18"},{"key":"121095","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/nrc.2016.18","DOI":"10.1038\/nrc.2016.18"},{"key":"121096","doi-asserted-by":"crossref","unstructured":"Albers AE, Qian X, Kaufmann AM, Coordes A. Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype. Sci Rep. 2017;7(1):16715.","DOI":"10.1038\/s41598-017-16918-w"},{"key":"121097","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41598-017-16918-w","DOI":"10.1038\/s41598-017-16918-w"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44027\/51035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44027\/51035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:35Z","timestamp":1756404275000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/44027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":55,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.44027","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}